A detailed history of Studio Investment Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Studio Investment Management LLC holds 24,905 shares of PFE stock, worth $738,682. This represents 0.16% of its overall portfolio holdings.

Number of Shares
24,905
Previous 20,853 19.43%
Holding current value
$738,682
Previous $578,000 20.42%
% of portfolio
0.16%
Previous 0.14%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$25.26 - $29.6 $102,353 - $119,939
4,052 Added 19.43%
24,905 $696,000
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $2.3 Million - $2.64 Million
-88,787 Reduced 80.98%
20,853 $578,000
Q4 2023

Feb 15, 2024

BUY
$26.13 - $33.94 $58,426 - $75,889
2,236 Added 2.08%
109,640 $3.16 Million
Q3 2023

Nov 15, 2023

BUY
$32.09 - $37.51 $715,093 - $835,872
22,284 Added 26.18%
107,404 $3.56 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $360,224 - $416,771
9,973 Added 13.27%
85,120 $3.12 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $50,143 - $65,279
-1,273 Reduced 1.67%
75,147 $3.07 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $27,763 - $36,242
-665 Reduced 0.86%
76,420 $3.92 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $129,310 - $157,856
-2,955 Reduced 3.69%
77,085 $3.37 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $111,904 - $132,683
-2,405 Reduced 2.92%
80,040 $4.2 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $12,352 - $15,306
-270 Reduced 0.33%
82,445 $4.27 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $35,535 - $52,675
-860 Reduced 1.03%
82,715 $4.88 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $3.28 Million - $4.21 Million
83,575 New
83,575 $3.6 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Studio Investment Management LLC Portfolio

Follow Studio Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Studio Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Studio Investment Management LLC with notifications on news.